Abstract: A pharmaceutical composition for treating cancer, in particular drug resistant cancer, comprising an effective amount of bifunctional alkylating agent, an effective amount of a DNA repair inhibitor, and a pharmaceutically acceptable carrier.
Type:
Application
Filed:
October 27, 2010
Publication date:
July 25, 2013
Applicant:
Academai Sinica
Inventors:
Te-Chang Lee, Tsann-Long Su, Tang-Chiao Chiou